Queens Cancer Center Minority-Based Community Clinical Oncology Program

皇后癌症中心少数民族社区临床肿瘤学项目

• 批准号: 8854543
• 负责人: Margaret margaret Kemeny
• 金额: $ 20.61万
• 依托单位: NEW YORK CITY HEALTH AND HOSPITALS CORPORATION
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-01 至 2015-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8854543
• 关键词: Area; Award; Cancer Center; Cancer Control; Clinical Trials; Communities; Community Clinical Oncology Program; Community Health Education; Diagnostic Neoplasm Staging; Disease; Early Diagnosis; Early treatment; Funding; Grant; Health; Health care facility; Hospitals; Immigrant; Insurance; Low income; Malignant Neoplasms; Minority; Minority Groups; Minority-Based Community Clinical Oncology Program; Mission; New York City; Outcome; Patients; Population; Prevention; Process; Public Hospitals; Qualifying; Recording of previous events; Research; Research Infrastructure; Resources; Staging; System; Training Programs; United States National Institutes of Health; Urban Hospitals; base; cancer care; cancer therapy; control trial; improved; outreach; patient population; programs; socioeconomics; treatment trial

DESCRIPTION (provided by applicant): The Queens Cancer Center (QCC) Minority-Based Community Clinical Oncology Program (MBCCOP) is the first National Institute of Health (NIH) funded grant, awarded to the public hospital system of New York City known as the Health and Hospital Corporation (HHC). QCC is part of the Queens Health Network (QHN) which is comprised of the only two public hospitals in Queens, Queens Hospital Center (QHC) and Elmhurst Hospital Center (EHC). Since the population of QHN is 92% minorities, we are uniquely qualified for this minority program. Since its inception in 2002, the QCC has been dedicated to bringing the best possible cancer care to the people in Queens who were previously underserved, including minority patients, recent immigrants and patients without insurance or means. The population served by the Queens Health Network has an unfortunate history of late stage cancers of all kind and. poorer survival. The mission of QCC is to reduce the rate of late stage disease and to improve the care for cancer. The strategies to accomplish this includes education of the community, introduction of cancer control trials, outreach for early detection programs and state of the art cancer care including access to cancer treatment trials. The patient population of QHN is overwhelmingly from minority groups who usually do not have access to clinical trials. The QHN is the only health facility in Queens, a borough more than 2 million people that offers access to multi-institutional treatment trials. Since the MBCCOP was awarded (September of 2010) the infrastructure was put in place to combine the resources of both centers (QHC and EHC) to assure access of patients to appropriate clinical trials. The process has been slow and is still evolving. It required hiring research staff and developing a quality training program in areas where previously no research was in place. We now have the staff and infrastructure in place to carry out the mission of MBCCOP going forward to increase access to clinical trials for our patients.

描述（由申请人提供）：皇后癌症中心 (QCC) 少数族裔社区临床肿瘤学计划 (MBCCOP) 是美国国立卫生研究院 (NIH) 资助的第一个赠款，授予纽约市公立医院系统（称为健康与医院公司 (HHC)）。 QCC 是皇后区健康网络 (QHN) 的一部分，该网络由皇后区仅有的两家公立医院：皇后区医院中心 (QHC) 和埃尔姆赫斯特医院中心 (EHC) 组成。由于 QHN 的人口中有 92% 是少数民族，因此我们具有参与该少数民族计划的独特资格。自 2002 年成立以来，QCC 一直致力于为皇后区以前服务不足的人们提供最好的癌症护理，包括少数族裔患者、新移民和没有保险或经济来源的患者。皇后区健康网络服务的人群有各种晚期癌症的不幸历史。生存能力较差。 QCC 的使命是降低晚期疾病的发生率并改善癌症护理。实现这一目标的策略包括社区教育、引入癌症控制试验、早期推广 检测计划和最先进的癌症护理，包括获得癌症治疗试验。 QHN 的患者群体绝大多数来自通常无法参加临床试验的少数群体。 QHN 是皇后区唯一一家提供多机构治疗试验的医疗机构，皇后区人口超过 200 万。自 MBCCOP 被授予（2010 年 9 月）以来，基础设施已到位，以结合两个中心（QHC 和 EHC）的资源，以确保患者能够参加适当的临床试验。这个过程很缓慢并且仍在不断发展。它需要雇用研究人员并在以前没有研究的领域制定高质量的培训计划。我们现在拥有适当的人员和基础设施来执行 MBCCOP 的使命，继续增加患者参与临床试验的机会。